查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
全球細胞分揀市場 - 2023-2030年
市場調查報告書
商品編碼
1297797

全球細胞分揀市場 - 2023-2030年

Global Cell Sorting Market - 2023-2030
出版日期: | 出版商: DataM Intelligence | 英文 195 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

市場概況

全球細胞分揀市場在2022年達到2.365億美元，預計到2030年將見證有利可圖的成長，達到3.898億美元。在2023-2030年的預測期間，全球細胞分揀市場預計將呈現6.6%的複合成長率。

細胞分選在研究、臨床診斷和治療方面有許多應用。它使分離稀有細胞群成為可能，包括幹細胞或循環腫瘤細胞，以便進一步分析。此外，它使純化特定的細胞類型更容易，用於治療，如開發基於細胞的藥物或研究免疫細胞群。

然而，設備的高成本、嚴格的法規、熟練人員的缺乏以及發展中國家對細胞分揀技術的認知不足是阻礙細胞分揀市場成長的一些因素。

市場動態

慢性疾病負擔的上昇在預測期內推動了全球細胞分揀市場的成長

近60%的美國成年人患有至少一種慢性疾病。美國的主要死因包括糖尿病、癌症和心血管疾病等慢性疾病。心臟病、癌症、中風、慢性阻塞性肺病和糖尿病佔所有死亡人數的三分之二以上。

根據CDC的數據，全國每年3.8兆美元的醫療費用中，有90%是由慢性病患者和精神健康問題引起的。根據對抗慢性病夥伴關係最近的一份報告，到2030年，美國治療七種最流行的慢性病的費用每年將達到2兆美元，或每人8,600美元。根據同一份報告，減少有害行為可能每年防止110萬人死亡。

不斷成長的生物製藥業在預測期內推動了全球細胞分揀市場的成長

美國最大的產業之一是生物製藥，每年價值數十億美元，對美國經濟和使用其產品的病人至關重要。由於CDMO生物製品公司的出現，這項業務正在經歷巨大的擴張，這些公司比以前更快地產生藥品。

這個行業的擴張也歸因於世界人口的擴大。世界人口的需求增加了生物製藥企業的壓力，但也讓它吸引了更多的投資，提高了利潤率，並進行了擴張。

個性化醫療的擴展提供了全球細胞分選市場的成長機會

有了個性化醫療，就有可能將"一刀切"的診斷、用藥和預防方法轉變為個性化的方法。根據病人的獨特特徵進行有針對性的治療是個性化醫療的目標。識別和分離特定的細胞類型以進行客製化治療，在很大程度上取決於細胞分揀技術。隨著個性化醫療的發展，對細胞分選技術的需求預計將上升。

COVID-19影響分析

COVID-19大流行病對細胞分揀市場產生了積極影響。免疫反應的變異性和COVID-19對各種細胞類型的影響已經利用單細胞分析技術（包括細胞分選）進行了廣泛的研究。這場大流行加強了單細胞分析技術，並通過強調理解單個細胞的特徵和反應的需要而增加了對細胞分揀技術的需求。

俄烏衝突分析

俄烏戰爭對細胞分揀市場的影響是複雜和多面的。用於在受影響地區建設醫療基礎設施的資源、注意力和資金可能會被沖突及其後果所轉移。這可能會影響尖端技術，如細胞分揀，在醫療保健和研究背景下的採用和使用。

目錄

第一章：方法和範圍

  • 研究方法
  • 報告的研究目標和範圍

第二章：定義和概述

第三章：執行摘要

  • 按技術抽查
  • 按產品和服務分類
  • 按應用分類
  • 按終端用戶分類
  • 按地區分類

第四章：動態變化

  • 影響因素
    • 驅動因素
      • 越來越多的慢性病檢測
    • 限制因素
      • 高成本和服務
    • 機會
      • 技術進步
    • 影響分析

第五章：行業分析

  • 波特的五力分析
  • 供應鏈分析
  • 未滿足的需求
  • 監管分析

第六章：COVID-19分析

  • 對COVID-19的分析
    • COVID-19之前的情況
    • COVID-19期間的情況
    • COVID-19之後的情況
  • 在COVID-19期間的定價動態
  • 需求-供應譜系
  • 大流行期間與市場有關的政府計劃
  • 製造商的戰略計劃
  • 結語

第7章：俄羅斯-烏克蘭戰爭分析

第八章：人工智慧分析

第九章：按技術分類

  • 螢光激活細胞分選(FACS)
  • 磁激活細胞分揀(MACS)
  • 微機電系統(MEMS) 微流控技術
  • 密度梯度離心法
  • 免疫密度細胞分離
  • 沉澱法
  • 其他

第十章：按產品和服務分類

  • 細胞分揀機
  • 細胞分揀試劑和消耗品
  • 細胞分揀服務

第十一章：按應用分類

  • 臨床應用
  • 研究應用
    • 免疫學和癌症研究
    • 幹細胞研究
    • 藥物發現
    • 其他研究應用

第十二章：按終端用戶分類

  • 研究機構
  • 製藥和生物技術公司
  • 醫院和臨床測試實驗室
  • 醫學院和學術機構

第十三章：按地區分類

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 歐洲其他地區
  • 南美洲
    • 巴西
    • 阿根廷
    • 南美其他地區
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 澳大利亞
    • 亞太其他地區
  • 中東和非洲

第十四章：競爭格局

  • 競爭格局
  • 產品標杆
  • 公司佔有率分析
  • 主要發展和戰略

第十五章：公司簡介

  • Bio-Rad Laboratories, Inc.
    • 公司概述
    • 產品組合和說明
    • 財務概況
    • 主要發展情況
  • Sony Biotechnology Inc.
  • BD
  • Merck KGaA
  • Danaher Corporation
  • Miltenyi Biotec GmbH
  • Affymetrix, Inc
  • Sysmex Partec GmbH
  • On-Chip Biotechnologies Co., Ltd.
  • Thermo Fisher Scientific

第16章：附錄

簡介目錄
Product Code: BT1895

Market Overview

The Global Cell Sorting Market reached US$ 236.5 million in 2022 and is projected to witness lucrative growth by reaching up to US$ 389.8 million by 2030. The Global Cell Sorting Market is expected to exhibit a CAGR of 6.6% during the forecast period 2023-2030.

Cell sorting has numerous applications in research, clinical diagnostics, and therapeutics. It makes it possible to separate rare cell groups, including stem cells or circulating tumor cells, for further analysis. Additionally, it makes it easier to purify particular cell types for therapeutic uses like developing cell-based medicines or researching immune cell populations.

However, the high cost of devices, stringent regulations, lack of skilled personnel and lack of awareness of cell sorting technology in developing countries are some factors hindering the growth of the cell sorting market.

Market Dynamics

The Rising Chronic Disease Burden is Boosting the Global Cell Sorting Market Growth During the Forecast Period

Nearly 60% of American adults suffer from at least one chronic illness. The major causes of death in the US include chronic diseases like diabetes, cancer, and cardiovascular disease. Heart disease, cancer, stroke, chronic obstructive pulmonary disease, and diabetes account for over two-thirds of all fatalities.

According to the CDC, 90% of the nation's $3.8 trillion in annual healthcare costs are attributable to persons with chronic illnesses and mental health issues. According to a recent report by the Partnership to Fight Chronic Disease, by 2030, the expense of treating the seven most prevalent chronic diseases in the United States will total $2 trillion annually or $8,600 per person. According to the same report, reducing harmful behaviors might prevent 1,100,000 deaths annually.

The Growing Biopharmaceutical Industry is Boosting the Global Cell Sorting Market Growth During the Forecast Period

One of the largest industries in America is biopharma, which is worth billions of dollars annually and is crucial to the American economy and the patients who use their products. This business is experiencing tremendous expansion due to the emergence of CDMO Biologics companies, which are generating pharmaceuticals more quickly than before.

The expansion of this industry is also attributed to an expanding world population. The demand from the world's population has increased pressure on the biopharma business, but it has also allowed it to attract more investment, increase profitability, and expand.

The Expansion of Personalized Medicine Provides the Global Cell Sorting Market Growth Opportunities

With personalized medicine, it's possible to transform a "one size fits all" approach to diagnosis, medication, and prevention into an individualized one. Targeted treatments based on unique patient traits are the goal of personalized medicine. Identifying and isolating particular cell types for customized therapeutics depend heavily on cell sorting technology. The demand for cell sorting technology is anticipated to rise as personalized medicine grows.

COVID-19 Impact Analysis

The COVID-19 pandemic has had a positive impact on the cell sorting market. The variability of the immune response and the effects of COVID-19 on various cell types have been extensively studied using single-cell analytic techniques, including cell sorting. The pandemic has enhanced single-cell analysis techniques and increased demand for cell sorting technology by highlighting the need to comprehend individual cells' traits and reactions.

Russia-Ukraine Conflict Analysis

The impact of the Russia-Ukraine war on the cell sorting market is complex and multifaceted. Resources, attention, and finance for the construction of healthcare infrastructure in the impacted areas may be diverted by the conflict and its aftermath. This might affect how cutting-edge technologies, like cell sorting, are adopted and used in healthcare and research contexts.

Segment Analysis

The Global Cell Sorting Market is segmented based on technology, product and services, application, End-user, and region.

The Fluorescence-Activated Cell Sorting (FACS) Segment is Expected to Hold a Dominant Position in the Market Over the Forecast Period

The fluorescence-activated cell sorting (FACS) segment accounted for the highest market stake, accounting for approximately 43.6% of the cell sorting market in 2022. The flow cytometry technique, fluorescence-activated cell sorting (FACS), is specialized. Using the unique light scattering and fluorescence properties of each cell, it offers a way for dividing a heterogeneous mixture of living cells into two or more containers, one cell at a time.

It is a practical scientific tool since it allows for the quick, accurate, and quantitative recording of fluorescence signals from individual cells as well as the physical segregation of cells of specific interest.

Geographical Analysis

Increasing Collaborations And Product Launches by the Key Players, and Increasing FDA Approvals, Dominate the North American Region

North America is expected to dominate the cell sorting market, accounting for around 39.6%. The market player applies strategies such as product launches and collaboration to expand their business.

For instance, in January 2023, Thermo Fisher Scientific, the leader in serving science, launched the Bigfoot Spectral Cell Sorter in India. The groundbreaking cell sorting system combines spectral sorting and analysis with traditional sorting to produce quick, simple-to-use cell sorting.

Competitive Landscape

The major global players in the market include: Bio-Rad Laboratories, Inc., Sony Biotechnology Inc., BD, Merck KGaA, Danaher Corporation, Miltenyi Biotec GmbH, Affymetrix, Inc., Sysmex Partec GmbH, On-Chip Biotechnologies Co., Ltd., Thermo Fisher Scientific among others.

Why Purchase the Report?

  • To visualize the Global Cell Sorting Market segmentation based on the technology, product and services, application, End-user, and region and understand key commercial assets and players.
  • Identify commercial opportunities by analyzing trends and co-development.
  • Excel data sheet with numerous data points of cell sorting market-level with all segments.
  • PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
  • Product mapping available as Excel consisting of key products of all the major players.

The Global Cell Sorting Market Report Would Provide Approximately 69 Tables, 70 Figures And 195 pages.

Target Audience 2023

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Technology
  • 3.2. Snippet by Product and Services
  • 3.3. Snippet by Application
  • 3.4. Snippet by End-user
  • 3.5. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Increasing number of chronic disease testing
    • 4.1.2. Restraints
      • 4.1.2.1. High costs and services
    • 4.1.3. Opportunity
      • 4.1.3.1. Technological advancements
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's 5 Forces Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Unmet Needs
  • 5.4. Regulatory Analysis

6. COVID-19 Analysis

  • 6.1. Analysis of COVID-19
    • 6.1.1. Scenario Before COVID-19
    • 6.1.2. Scenario During COVID-19
    • 6.1.3. Scenario Post COVID-19
  • 6.2. Pricing Dynamics Amid COVID-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During the Pandemic
  • 6.5. Manufacturers' Strategic Initiatives
  • 6.6. Conclusion

7. Russia-Ukraine War Analysis

8. Artificial Intelligence Analysis

9. By Technology

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 9.1.2. Market Attractiveness Index, By Technology
  • 9.2. Fluorescence-activated cell sorting (FACS)*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. Magnetic-activated cell sorting (MACS)
  • 9.4. Micro-Electromechanical Systems (MEMS) Microfluidics
  • 9.5. Density Gradient Centrifugation
  • 9.6. Immunodensity Cell Separation
  • 9.7. Sedimentation
  • 9.8. Others

10. By Product and Services

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product and Services
    • 10.1.2. Market Attractiveness Index, By Product and Services
  • 10.2. Cell Sorters*
    • 10.2.1. Introduction
    • 10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 10.3. Cell Sorting Reagents & Consumables
  • 10.4. Cell Sorting Services

11. By Application

    • 11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.1.2. Market Attractiveness Index, By Application
  • 11.2. Clinical Applications*
    • 11.2.1. Introduction
    • 11.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 11.3. Research Applications
    • 11.3.1. Immunology & Cancer Research
    • 11.3.2. Stem Cell Research
    • 11.3.3. Drug Discovery
    • 11.3.4. Other Research Applications

12. By End user

  • 12.1. Introduction
    • 12.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End user
    • 12.1.2. Market Attractiveness Index, By End user
  • 12.2. Research Institutes*
    • 12.2.1. Introduction
    • 12.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 12.3. Pharmaceutical & Biotechnology Companies
  • 12.4. Hospitals and Clinical Testing Laboratories
  • 12.5. Medical Schools and Academic Institutions

13. By Region

  • 13.1. Introduction
    • 13.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 13.1.2. Market Attractiveness Index, By Region
  • 13.2. North America
    • 13.2.1. Introduction
    • 13.2.2. Key Region-Specific Dynamics
    • 13.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 13.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product and Services
    • 13.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 13.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End user
    • 13.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 13.2.7.1. The U.S.
      • 13.2.7.2. Canada
      • 13.2.7.3. Mexico
  • 13.3. Europe
    • 13.3.1. Introduction
    • 13.3.2. Key Region-Specific Dynamics
    • 13.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 13.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product and Services
    • 13.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 13.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End user
    • 13.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 13.3.7.1. Germany
      • 13.3.7.2. The U.K.
      • 13.3.7.3. France
      • 13.3.7.4. Italy
      • 13.3.7.5. Spain
      • 13.3.7.6. Rest of Europe
  • 13.4. South America
    • 13.4.1. Introduction
    • 13.4.2. Key Region-Specific Dynamics
    • 13.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 13.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product and Services
    • 13.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 13.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End user
    • 13.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 13.4.7.1. Brazil
      • 13.4.7.2. Argentina
      • 13.4.7.3. Rest of South America
  • 13.5. Asia-Pacific
    • 13.5.1. Introduction
    • 13.5.2. Key Region-Specific Dynamics
    • 13.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 13.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product and Services
    • 13.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 13.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End user
    • 13.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 13.5.7.1. China
      • 13.5.7.2. India
      • 13.5.7.3. Japan
      • 13.5.7.4. Australia
      • 13.5.7.5. Rest of Asia-Pacific
  • 13.6. Middle East and Africa
    • 13.6.1. Introduction
    • 13.6.2. Key Region-Specific Dynamics
    • 13.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 13.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product and Services
    • 13.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 13.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End user

14. Competitive Landscape

  • 14.1. Competitive Scenario
  • 14.2. Product Benchmarking
  • 14.3. Company Share Analysis
  • 14.4. Key Developments and Strategies

15. Company Profiles

  • 15.1. Bio-Rad Laboratories, Inc.*
    • 15.1.1. Company Overview
    • 15.1.2. Product Portfolio and Description
    • 15.1.3. Financial Overview
    • 15.1.4. Key Developments
  • 15.2. Sony Biotechnology Inc.
  • 15.3. BD
  • 15.4. Merck KGaA
  • 15.5. Danaher Corporation
  • 15.6. Miltenyi Biotec GmbH
  • 15.7. Affymetrix, Inc
  • 15.8. Sysmex Partec GmbH
  • 15.9. On-Chip Biotechnologies Co., Ltd.
  • 15.10. Thermo Fisher Scientific

LIST NOT EXHAUSTIVE

16. Appendix

  • 16.1. About Us and Services
  • 16.2. Contact Us